5rl2
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5rl2 is ON HOLD Authors: Fearon, D., Owen, C.D., Douangamath, A., Lukacik, P., Powell, A.J., Strain-Damerell, C.M., Zaidman, D., Krojer, T., Gehrtz,...) |
|||
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-26 (Mpro-x3115)== | |
- | + | <StructureSection load='5rl2' size='340' side='right'caption='[[5rl2]], [[Resolution|resolution]] 1.48Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5RL2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5RL2 FirstGlance]. <br> | |
- | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.48Å</td></tr> | |
- | [[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=DMS:DIMETHYL+SULFOXIDE'>DMS</scene>, <scene name='pdbligand=VEM:N-(4-tert-butylphenyl)-N-[(1R)-2-[(2-methoxyethyl)amino]-2-oxo-1-(pyridin-3-yl)ethyl]propanamide'>VEM</scene></td></tr> |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5rl2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5rl2 OCA], [https://pdbe.org/5rl2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5rl2 RCSB], [https://www.ebi.ac.uk/pdbsum/5rl2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5rl2 ProSAT]</span></td></tr> |
- | [[ | + | </table> |
- | [[ | + | __TOC__ |
- | [[ | + | </StructureSection> |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: Brandao-Neto | + | [[Category: Aimon A]] |
- | [[Category: | + | [[Category: Brandao-Neto J]] |
- | [[Category: Fearon | + | [[Category: Carbery A]] |
- | [[Category: | + | [[Category: Douangamath A]] |
- | [[Category: | + | [[Category: Dunnett L]] |
- | [[Category: | + | [[Category: Fearon D]] |
- | [[Category: | + | [[Category: Gehrtz P]] |
- | [[Category: Powell | + | [[Category: Gorie-Stone TJ]] |
- | [[Category: Skyner | + | [[Category: Krojer T]] |
- | [[Category: | + | [[Category: London N]] |
- | [[Category: | + | [[Category: Lukacik P]] |
- | [[Category: | + | [[Category: Owen CD]] |
- | [[Category: Zaidman | + | [[Category: Powell AJ]] |
- | [[Category: | + | [[Category: Skyner R]] |
+ | [[Category: Strain-Damerell CM]] | ||
+ | [[Category: Walsh MA]] | ||
+ | [[Category: Wild C]] | ||
+ | [[Category: Zaidman D]] | ||
+ | [[Category: Von Delft F]] |
Current revision
PanDDA analysis group deposition of computational designs of SARS-CoV-2 main protease covalent inhibitors -- Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-26 (Mpro-x3115)
|
Categories: Large Structures | Aimon A | Brandao-Neto J | Carbery A | Douangamath A | Dunnett L | Fearon D | Gehrtz P | Gorie-Stone TJ | Krojer T | London N | Lukacik P | Owen CD | Powell AJ | Skyner R | Strain-Damerell CM | Walsh MA | Wild C | Zaidman D | Von Delft F